Description

RETATRUTIDE 40MG

High Strength Triple Agonist Research Peptide

Retatrutide 40MG is an advanced metabolic research peptide being investigated for its activity across GLP 1, GIP and glucagon receptors.

This triple receptor profile makes Retatrutide particularly relevant to research involving metabolic signalling, energy expenditure, appetite pathways, glucose regulation and body composition.

RESEARCH AREAS

• Metabolic research
• Energy expenditure
• Appetite and satiety signalling
• Body composition models
• GLP 1, GIP and glucagon pathways
• Multi receptor peptide research

PRODUCT DETAILS

Compound: Retatrutide
Strength: 40MG
Form: Lyophilised Powder
Grade: Research Grade
Testing: Third Party Tested
Storage: 2°C to 8°C
Supplier: Meditech Plus Australia

RETATRUTIDE 40MG AUSTRALIA

Meditech Plus Australia supplies Retatrutide 40MG from locally held Australian stock, with controlled cold storage, professional packaging and fast Australia wide dispatch.

Includes: 1 × Retatrutide 40MG Research Vial

RESEARCH USE ONLY

For laboratory, analytical and scientific research purposes only.

Not for human consumption.